FDA Warns on Aortic Aneurysms With Fluoroquinolones

Manufacturers of fluoroquinolones such as ciprofloxacin (Cipro) must now warn about risk of aortic dissection or aneurysm in certain patients associated with systemic use of these antibiotics, the FDA said Thursday.


It's the latest in a series of warnings related to this class of antibiotics. In July, the FDA required manufacturers to update labeling to warn about mental health issues and potential low blood sugar adverse reactions; and before that, the agency had warned about adverse musculoskeletal effects and peripheral neuropathy. The FDA had also indicated that this class of agents should not be used for uncomplicated infections owing the risk of adverse effects.


(Click for full story)




3 views